Health Care: Drugs

Infinity Pharmaceuticals Inc (INFI: NASDAQ)

$9.09 -0.33 | -3.5%
07/31/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 0.00 47.11M 92.77M 71.33M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 47.11M 92.77M 71.33M
Selling, General, and Administrative Expenses 27.92M 27.88M 22.72M 21.07M
Research & Development 99.76M 118.60M 108.58M 99.23M
Operating Income before D & A (EBITDA) -127.68M -99.36M -38.53M -48.97M
Depreciation & Amortization 4.02M 3.30M 4.70M 5.41M
Interest Income 0.00 559.00K 326.75K 463.01K
Other Income - Net 896.00K 46.75M 0.00 733.44K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -130.80M -55.35M -42.91M -53.19M
Interest Expense 0.00 1.91M 1.84M 1.91M
Pre-Tax Income -130.80M -57.26M -44.75M -55.10M
Income Taxes 0.00 0.00 0.00 -700.32K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -126.78M -53.96M -40.04M -48.98M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -126.78M -53.96M -40.04M -48.98M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -126.78M -53.96M -40.04M -48.98M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-126.78M -53.96M -40.04M -48.98M
Preferred Dividends
Net Income Available To Common -126.78M -53.96M -40.04M -48.98M
Basic EPS from Continuing Ops. -2.64 -1.70 -1.50 -1.86
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -2.64 -1.70 -1.50 -1.86
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.64 -1.70 -1.50 -1.86
Basic Normalized Net Income/Share -2.64 -1.70 -1.50 -1.86
EPS fr Continuing Ops. -2.64 -1.70 -1.50 -1.86
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -2.64 -1.70 -1.50 -1.86
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.64 -1.70 -1.50 -1.86
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.64 -1.70 -1.50 -1.86
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with INFI

Latest INFI Headlines from TheStreet

More Financial News for INFI

Press Releases for INFI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter